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ABSTRACT
Aims: We sought to evaluate trachoma prevalence in all suspected-endemic areas of Benin.
Methods: We conducted population-based surveys covering 26 districts grouped into 11 evalua-
tion units (EUs), using a two-stage, systematic and random, cluster sampling design powered at
EU level. In each EU, 23 villages were systematically selected with population proportional to size;
30 households were selected from each village using compact segment sampling. In selected
households, we examined all consenting residents aged one year or above for trichiasis, tracho-
matous inflammation – follicular (TF), and trachomatous inflammation – intense. We calculated
the EU-level backlog of trichiasis and delineated the ophthalmic workforce in each EU using local
interviews and telephone surveys.
Results: At EU-level, the TF prevalence in 1–9-year-olds ranged from 1.9 to 24.0%, with four EUs
(incorporating eight districts) demonstrating prevalences ≥5%. The prevalence of trichiasis in
adults aged 15+ years ranged from 0.1 to 1.9%. In nine EUs (incorporating 19 districts), the
trichiasis prevalence in adults was ≥0.2%. An estimated 11,457 people have trichiasis in an area
served by eight ophthalmic clinical officers.
Conclusion: In northern Benin, over 8000 people need surgery or other interventions for trichiasis
to reach the trichiasis elimination threshold prevalence in each EU, and just over one million
people need a combination of antibiotics, facial cleanliness and environmental improvement for
the purposes of trachoma’s elimination as a public health problem. The current distribution of
ophthalmic clinical officers does not match surgical needs.
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Introduction
The year 2020 is the target date for the global elimination of
trachoma as a public health problem.1 As the first step to
achieving this goal, mapping is needed to assess the ende-
micity of trachoma and determine the need for
interventions.2
In 2012, the World Health Organization (WHO) esti-
mated that 21 million people had active (inflammatory)
trachoma (trachomatous inflammation – follicular, TF
and/or trachomatous inflammation – intense, TI),3 and
more than 7 million people had in-turned eyelashes (tra-
chomatous trichiasis) that could lead to corneal opacity and
blindness.4 Sub-Saharan Africa bears the largest burden of
disease, with more than 80% of the cases of trachoma.5 An
assessment of trichiasis surgeries conducted in northern
Benin in 2013 suggested that some districts were
suspected-trachoma-endemic at a level that constitutes a
public health problem, but in the absence of survey data, the
need for public-health-level interventions was not known.
We sought to map suspected endemic areas in Benin in
order to decide if and where to implement trachoma con-
trol efforts.
Methods
This series of surveys was undertaken as part of the Global
Trachoma Mapping Project (GTMP),6 an international
effort to complete trachoma mapping in all potentially
endemic populations.
Benin, a country of 11 million inhabitants sharing bor-
ders with Nigeria (to the east), Togo (to the west), and
CONTACT Amadou Alfa Bio bioamadou@yahoo.fr National Control Program of Communicable Diseases, Ministry of Health, Benin.
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Burkina Faso and Niger (to the north) is divided into 12
departments consisting of 77 districts. A national audit of
data on the conduct of surgery for trichiasis, conducted in
2013, identified the districts to be mapped for trachoma:
only 26 districts, all in the northern region, were identified,
and there was no evidence or suspicion of trachoma being
endemic in the remainder of the country. The total popula-
tion of the northern region is 3,382,083.7 Urban areas
(Parakou and Natitingou) were not considered trachoma-
suspect and were not included in the survey. Some districts
were combined with adjacent, geographically and socio-
culturally similar districts to create 11 separate evaluation
units (EUs) for survey purposes; the number of districts in
each EU ranged fromone to four. In general,WHO recom-
mends that trachoma surveys be implemented in popula-
tions of between 100,000 and 250,000 people;8 the
estimated 2014 populations of our EUs ranged from
114,659 (N’dali, Borgou Département) to 542,605 (Bassila
Copargo Djougou Ouake, Donga Département) (Table 1).
(The nameof eachEU (Tables 1 and 2) is a concatenation of
the names of its constituent districts.)
Each of the 11 separate cross-sectional population-
based surveys conducted was designed to obtain EU-
level prevalence estimates for TF in children aged 1–9
years; and trichiasis in persons aged 15 years and above.
The GTMP survey methods that were used in this study
are described in detail elsewhere.9 Briefly, the target sam-
ple size was calculated to estimate, at EU level, an
expected TF prevalence of 10% in 1–9-year-olds with an
absolute precision of 3%, using a design effect of 2.65 and
inflation by a factor of 1.2 to allow for non-response. The
sample size of 1222 children for each EU was chosen as
follows: in each EU, we systematically selected 23 clusters
(villages) by probability proportional to size sampling.We
then (because of the absence of household registers)
selected 30 households in each selected village by compact
segment sampling; this entailed drawing a map of the
village and creating approximately equally-sized segments
of about 30 households, and selecting one segment by
random draw. Going house to house, field teams invited
all residents of households in selected segments aged 1
year and above to be examined. For survey purposes, a
household resident was defined as a person who, for the
previous month or longer, shared one or more premises
connected to the place where the head of the household
usually sleeps (regardless of their relationship to the head
of the household) and who had meals more than 3 nights
per week at that location.
We examined all consenting residents for evidence
of trichiasis, TF and TI, using 2.5× magnifying loupes.
Additionally, we collected Global Positioning System
coordinates outside the most prominent building of
each household, and household-level data on access to
water, sanitation, and hygiene.9 For individuals found
to have trichiasis, to obtain information on previous
interaction with the health care system, we asked ques-
tions to determine whether health workers had pre-
viously recommended trichiasis surgery or epilation.
To prepare for the surveys, in November 2013, two
ophthalmologists (AAB and JEB) underwent training
and certification as GTMP grader trainers in Ethiopia.
They then conducted the training of survey graders and
recorders in Benin, using version 2 of the GTMP train-
ing protocols.9,10 All survey graders were ophthalmic
clinical officers (OCOs), dedicated eye care profes-
sionals with at least two years of training in eye care.
A minimum kappa of 0.7 for the diagnosis of TF in an
inter-grader agreement test with 50 eyes of 50 children
was required to pass the grading examination. Of the 14
OCOs enrolled in the training programme, 11 were
certified as GTMP graders and became members of
survey teams. Survey recorders completed training on
data capture using the GTMP-LINKS app on Android
smartphones.
Prior to fieldwork, we undertook a pilot test in a
village not selected for any of the surveys. The 11 teams
(each containing one grader and one recorder) were
then deployed to the field from March to April 2014. In
November 2014, we re-assessed the EU of Tchaourou
because an inadequate number of 1–9-year-old children
had been examined there. In April 2015, we surveyed
Natitingou rural because adjacent districts were ende-
mic for trachoma, based on the 2014 data. Therefore 13
further clusters were added to the previously sampled
clusters for the Natitingou EU using the same GTMP
methodology.
We uploaded all data to the GTMP secure server,
and undertook standardized analyses to estimate the
prevalence of TF in children aged 1–9 years and
trichiasis in adults aged 15 years and above, in
each EU. We standardized prevalence estimates for
age and sex based on rural Benin population data, as
previously described.9 We calculated the backlog of
trichiasis cases in each EU (calculated by multiply-
ing the prevalence of trichiasis by the census popu-
lation of adults). For planning purposes, we also
calculated the current number of people requiring
surgery or other interventions for trichiasis in order
to reach the WHO elimination threshold of less
than 0.2% of adults having trichiasis (defined as
the backlog minus the elimination threshold).11
Both the trichiasis backlog and the number needing
trichiasis management to reach the elimination
threshold include people with trichiasis, whether
they had any previous interaction with the health
system or not.
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Finally, we undertook an assessment of the eye care
human resources potentially available to manage tri-
chiasis in northern Benin. This included a standard
interview administered during a visit to 9 of the 14
OCOs in northern Benin, asking for the names, loca-
tions and contact details of ophthalmic colleagues,
identifying ophthalmic personnel working in the region
using snowball sampling. The five OCOs who could not
be visited were contacted by mobile phone.
Ethical clearance was obtained from the Comite
National d’Ethique pour la Recherche en Sante (070/
MS/DC/SGM/DFR/CNERS/SA), and from the ethics
committee of the London School of Hygiene &
Tropical Medicine (6319). Prior to examination, verbal
informed consent was obtained from adults for enroll-
ment of themselves and for children (aged under 15
years) in their care. Any participant found to have TF
and/or TI was treated with 1% tetracycline eye oint-
ment, and individuals with trichiasis or other ocular
conditions were referred to the nearest eye unit.
Results
Across the 11 EUs, in total, 7719 households were
surveyed in 266 clusters. A total of 46,471 people of
all ages were examined (range per EU: 2449–5630),
including 18,085 adults (6422 males; 11,663 females)
aged 15+ years, and 23,006 children (11,678 males;
11,328 females) aged 1–9 years (Table 1). The overall
participation rate was 91.5%, ranging across EUs from
87.8% to 99.2% (Table 1). The major reason for non-
participation was being away from the village at the
time of the survey.
The EU-level age-adjusted prevalence of TF in 1–9-
year-olds ranged from 1.9% to 24.0%. Four EUs, com-
prising eight districts, had TF prevalences above 5%,
warranting intervention (Table 1 and Figure 1). The
age-adjusted prevalence of TI in 1–9-year-olds was <2%
in all EUs except for the EU comprising the districts of
Boukoumbe, Toukountouna, and Natitingou in
Atacora Department, in which the prevalence was
5.4%. The age- and sex-adjusted prevalence of trichiasis
in adults ranged from 0.12% to 1.92% (Table 2 and
Figure 2). Nine EUs (19 districts) had trichiasis preva-
lences greater than 0.2% in adults, thus requiring public
health-level surgery interventions. The EU surveyed in
the department of Donga (comprising the districts
Bassila, Copargo, Djougou, and Ouake) and one of
the EUs in the department of Atacora (comprising the
districts Tanguiéta, Cobly, and Materi) had trichiasis
prevalences in adults of <0.2%. The estimated total
backlog of trichiasis in northern Benin is 11,457 people,
with an estimated 8155 individuals needing to be
offered appropriate management to meet the trichiasis
component of the definition of “elimination of tra-
choma as a public health problem.” Among 282 people
identified with trichiasis in the survey, 71 (25%) had
had previous trichiasis surgery, 57 (80%) of whom
came from the EU comprising the districts of
Boukoumbe, Toukountouna, and Natitingou in
Atacora Department.
In the 26 districts in northern Benin there are, at
present, 13 OCOs and four ophthalmologists. OCOs
received training at a number of training centers out-
side of Benin; experience in trichiasis surgery ranged
from none to only a few cases. Supervision of OCOs for
trichiasis surgery is limited to the OCOs in the Parakou
area. Five of the 13 OCOs and the four ophthalmolo-
gists are in the urban area of Parakou. There is no OCO
in Banikoara or Tchaourou, the two EUs with the high-
est numbers of people with trichiasis needing
intervention.
Discussion
These are the first population-based prevalence surveys
of trachoma in Benin, and their findings are now being
used to facilitate planning and implementation of the
SAFE strategy (surgery, antibiotics, facial cleanliness,
environmental improvement)12 in endemic districts.
Our work indicates that these endemic districts will
require different combinations of interventions, as pre-
valences of TF and trichiasis do not invariably exceed
the respective elimination thresholds in the same
places, as also observed in other trachoma endemic
countries, including Cameroon.13
Three of the countries bordering Benin (Nigeria,
Niger, and Burkina Faso) are endemic for trachoma,
while available evidence suggests that active trachoma
is not a public health problem in Togo.14 The Nigerian
states bordering northern Benin (Kwara, Niger,15 and
Kebbi) have a few trachoma endemic districts, but
prevalences there are not high. Large areas of the
Niger and Burkina Faso16 border zones are national
parks and forests in which population density is very
low. In fact, 2015 data available at www.trachomaatlas.
org suggest that, of districts bordering Benin, only
Dandi Local Government Area of Kebbi State, Nigeria
and Pama Department of Burkina Faso had most recent
TF prevalence estimates above the elimination thresh-
old. There is one transit route to Burkina Faso through
the districts of Natitingou and Toukountouna.
Boukoumbé is far from this transit route. In these
three districts, there is limited access to water, and
sanitation is generally poor; this may be part of the
reason for the high prevalence of TF in this area. The
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general absence of trachoma in the southern-most part
of the northern region surveyed here probably indicates
a low likelihood of disease being a public health pro-
blem further south. In addition, in 2012, the surgical
records of hospitals throughout Benin were reviewed;
no trichiasis cases had been operated on during the
previous 2 years.
As expected, the burden of trichiasis is mostly found in
areas with TF; this offers opportunities for case finding
during mass drug administration and other community-
based interventions. Nevertheless, there are 4246 people
with trichiasis (37% of the backlog calculated here) needing
management who live in areas in which the mass distribu-
tion of antibiotics is not indicated. The two EUs of
Banikoara and Tchaourou account for the highest number
of people needing trichiasis management (3896 or 48% of
the total requirement) yet there is no OCO in either.
Training (or re-training) the OCOs in Natitingou and
Malanville to undertake management of trichiasis is a
priority. While the long-term approach will be to place a
Figure 1. Prevalence of trachomatous inflammation – follicular (TF) in Benin.
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trained OCO in Banikoara and Tchaourou and support
them to provide trichiasis surgical services, a short-term
measure may be to organize outreach from neighboring
areas in which OCOs are based, after they have been
appropriately trained and certified.17
It is important to note that the 3302 people with
trichiasis constituting the difference between the back-
log and the number that must be treated to reach
elimination prevalence thresholds all still need inter-
ventions against trichiasis in order to prevent tracho-
matous visual impairment. An ongoing, funded
strategy to deliver services to individuals with incident
trichiasis is a requirement for validation of trachoma
elimination.
There were two EUs (four districts) in which TF pre-
valences were above 10%, thus indicating the need for at
least 3 years of annual mass drug administration of anti-
biotics and F and E interventions. In an additional two EUs
(four districts) in which prevalences of TF were between 5
and 9.9%, it is recommended that implementation of facial
cleanliness promotion and environmental improvement
are supplemented by one round of mass azithromycin
administration. In total, over one million people live in
areas that will require intervention to address active
Figure 2. Prevalence of trichiasis in Benin.
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trachoma. If these measures are successful at reducing the
prevalence of TF in children at impact survey, and if TF
prevalence subsequently remains below 5% during surveil-
lance, Benin will be on the pathway to elimination of
trachoma as a public health problem.
The major strengths of our series of surveys are the
use of gold-standard survey methodologies for estimat-
ing prevalence, good geographical sample coverage in
each EU, a high participation rate, rigorous training
and supervision, and standardized approaches to data
cleaning and analysis. The relatively large populations
of some EUs,8 and the fact that we did not include
examination for trachomatous conjunctival scarring3 in
eyes that had trichiasis,18 are both potential limitations.
Although it is possible that some small pockets of
trachoma were missed in surveyed districts, we believe
we have adequately delineated the areas of Benin in
which trachoma affects sufficiently large populations
to be considered a public health problem, and can
now confidently chart a course towards trachoma
elimination.
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